Targeted Therapies in Cancer

Myth or Reality?

Editors:

ISBN: 978-0-387-73897-0 (Print) 978-0-387-73898-7 (Online)

Table of contents (13 chapters)

  1. Front Matter

    Pages i-viii

  2. No Access

    Book Chapter

    Pages 1-4

    Causality in Medicine

  3. No Access

    Book Chapter

    Pages 5-18

    The Evolution of the Biomedical Paradigm in Oncology: Implications for Cancer Therapy

  4. No Access

    Book Chapter

    Pages 19-42

    Anticancer Drug Discovery and Development

  5. No Access

    Book Chapter

    Pages 43-53

    Beyond VEGF: Targeting Tumor Growth and Angiogenesis via Alternative Mechanisms

  6. No Access

    Book Chapter

    Pages 54-73

    Aurora Kinases and Their Inhibitors: More Than One Target and One Drug

  7. No Access

    Book Chapter

    Pages 74-87

    Signalling Pathways and Adhesion Molecules as Targets for Antiangiogenesis Therapy in Tumors

  8. No Access

    Book Chapter

    Pages 88-99

    Developing T-Cell Therapies for Cancer in an Academic Setting

  9. No Access

    Book Chapter

    Pages 100-111

    Anticancer Cell Therapy with TRAIL-Armed CD34+ Progenitor Cells

  10. No Access

    Book Chapter

    Pages 112-127

    Linking Inflammation Reactions to Cancer: Novel Targets for Therapeutic Strategies

  11. No Access

    Book Chapter

    Pages 128-143

    Clinical Development of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors: What Lessons Have We Learned?

  12. No Access

    Book Chapter

    Pages 144-154

    GIST As the Model of Paradigm Shift Towards Targeted Therapy of Solid Tumors: Update and Perspective on Trial Design

  13. No Access

    Book Chapter

    Pages 155-176

    Monoclonal Antibodies in the Treatment of Malignant Lymphomas

  14. No Access

    Book Chapter

    Pages 177-186

    Molecular Network Analysis using Reverse Phase Protein Microarrays for Patient Tailored Therapy

  15. Back Matter

    Pages 187-191